Cardurion Pharmaceuticals raises $260 million in Series B funding
Cardurion Pharmaceuticals, Inc.a Burlington, Massachusetts-based clinical-stage biotechnology company developing next-generation therapeutics to treat cardiovascular disease, has raised $260 million in Series B funding. The round...
Sift raises $17.5 million in Series A funding round
Sevenan El Segundo, California-based provider of a hardware sensor data observation platform, has raised $17.5 million in Series A funding. The round, which brought the...
